
Shares of New Jersey-based drug distributor Wellgistics Health WGRX.O rise 9.3% to $2.95 premarket
Company announces it is collaborating with Protega Pharmaceuticals to increase patient access to Protega's opioid, Roxybond
Roxybond is indicated for managing severe pain when other treatments are insufficient
WGRX has fallen 29% since its debut on February 21